Evidence map›Paper›PMID 27525511›Full record

ArticleACS chemical biology2016

Metabolic Labeling with an Alkyne-modified Isoprenoid Analog Facilitates Imaging and Quantification of the Prenylome in Cells.

Charuta C Palsuledesai, Joshua D Ochocki, Michelle M Kuhns, Yen-Chih Wang, Janel K Warmka, Dustin S Chernick, Elizabeth V Wattenberg, Ling Li, Edgar A Arriaga, Mark D Distefano

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. ACS chemical biology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Optimization of Metabolic Labeling with Alkyne-Containing Isoprenoid Probes.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Charuta C PalsuledesaiDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Joshua D OchockiDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Michelle M KuhnsDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Yen-Chih WangDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Janel K WarmkaDivision of Environmental Health Sciences, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Dustin S ChernickDepartment of Experimental and Clinical Pharmacology, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Elizabeth V WattenbergDivision of Environmental Health Sciences, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Ling LiDepartment of Experimental and Clinical Pharmacology, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Edgar A ArriagaDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Mark D DistefanoDepartment of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
University of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
TRAINING FOR FUTURE BIOTECHNOLOGY DEVELOPMENTT32GM008347 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SCHMIDT-DANNERT, CLAUDIA · 1990 to 2021
$11.0M
Quantitating Mitophagy in Skeletal Muscle ModelsR01AG020866 · NIA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ARRIAGA, EDGAR A · 2002 to 2021
$5.7M
Chemistry-Biology Interface Training GrantT32GM008700 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI DISTEFANO, MARK D · 1999 to 2018
$4.0M
MECHANISM AND FUNCTION OF PROTEIN PRENYLATIONR01GM058842 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI DISTEFANO, MARK D · 1998 to 2010
$2.6M
Enzymatic Protein LabelingR01GM084152 · NIGMS · UNIVERSITY OF MINNESOTA · PI DISTEFANO, MARK D · 2010 to 2019
$2.6M
Protective Mechanisms of Statins in Alzheimer's DiseaseR01AG031846 · NIA · UNIVERSITY OF MINNESOTA · PI LI, LING · 2008 to 2012
$1.5M
NCI NIH HHS P30 CA077598NIA NIH HHS R01 AG020866NIA NIH HHS R01 AG031846NIGMS NIH HHS R01 GM058842NIGMS NIH HHS R01 GM084152NIGMS NIH HHS T32 GM008347NIGMS NIH HHS T32 GM008700
6 · The paper itself

Abstract

Protein prenylation is a post-translational modification that is responsible for membrane association and protein-protein interactions. The oncogenic protein Ras, which is prenylated, has been the subject of intense study in the past 20 years as a therapeutic target. Several studies have shown a correlation between neurodegenerative diseases including Alzheimer's disease and Parkinson's disease and protein prenylation. Here, a method for imaging and quantification of the prenylome using microscopy and flow cytometry is described. We show that metabolically incorporating an alkyne isoprenoid into mammalian cells, followed by a Cu(I)-catalyzed alkyne azide cycloaddition reaction to a fluorophore, allows for detection of prenylated proteins in several cell lines and that different cell types vary significantly in their levels of prenylated proteins. The addition of a prenyltransferase inhibitor or the precursors to the native isoprenoid substrates lowers the levels of labeled prenylated proteins. Finally, we demonstrate that there is a significantly higher (22%) level of prenylated proteins in a cellular model of compromised autophagy as compared to normal cells, supporting the hypothesis of a potential involvement of protein prenylation in abrogated autophagy. These results highlight the utility of total prenylome labeling for studies on the role of protein prenylation in various diseases including aging-related disorders.

Indexed as

Protein PrenylationAlkynesAutophagyFlow CytometryHeLa CellsHumansTerpenesAlkynesTerpenes

Identifiers

PMID27525511
PMCPMC5074897
OpenAlexW2516612281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.